News

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.
Early abdominal CT may be warranted among patients with unknown or uncertain biochemical screening results for primary aldosteronism.
Glucopilot dynamic dosing algorithm was associated with improved glycemic control especially among subgroups with ...
Thyroid cancer burden attributable to high BMI was increasing between 1990 and 2021 in the US, especially among men and older ...
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...
Adolescents with PCOS demonstrated comparable weight loss to their reproductively normal peers after undergoing bariatric ...
Adrenal adenomas were associated with attenuated weight loss among patients with obesity or overweight using GLP-1 or GIP/GLP ...